Top Markets
Coin of the day
Bharat Immunologicals & Biologicals Corporation Limited Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limited

BIBCL
Rangering i aksjer #33476
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology... Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Aksjekurs
$0.17558081
Markedsverdi
$7.58M
Endring (1 dag)
-0.25%
Endring (1 år)
-30.30%
Land
IN
Handel Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)

Kategori

Driftsmargin for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL)
Driftsmargin per 2026 TTM: 0.00%
Ifølge Bharat Immunologicals & Biologicals Corporation Limited sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 0.00%. Ved slutten av 2026 hadde selskapet en driftsmargin på 0.00%.
Historikk for driftsmargin for Bharat Immunologicals & Biologicals Corporation Limited fra 2026 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
Ikke nok data for de angitte datoene.
Driftsmargin for lignende selskaper eller konkurrenter
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.